Gerry McDougall Partner, PwC Health Sciences

Gerry McDougall leads PwC’s US Oncology Practice serving academic and commercial research organizations across the healthcare continuum, and is responsible for leadership of the broad range of basic, translational and clinical research strategic and business planning services that PwC provides to academic and research organizations.  


In particular, Gerry specializes in the development of partnerships and the creation of new research ventures. During his leadership of the Health Sciences practice, clients have included CEO's, Presidents, Boards of Directors, prominent scientific leadership including Nobel Laureates, National Academy members, Lasker  Award recipients, leaders of patient advocacy groups, heads of R&D, Chief Scientific Officers, CMO's, the federal government and governors of several states. 

Over the past 5 years, Gerry's teams have helped secure billions of dollars for biomedical research and he has been instrumental in assisting prominent organizations such as the Knight Institute for Early Detection of Cancer and its clinical Director, Dr. Brian Druker, in developing strategies and plans to invest funds for the early detection of cancer. 

 

Gerry McDougall profile picture